$SLQT

SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure

SelectQuote (SLQT) has received a notice from the NYSE regarding non-compliance, as its average share price dropped below $1 for 30 consecutive trading days. The company has a six-month window to regain compliance, with management planning to leverage strong recent financial results, including a new $415 million credit facility, to support its position. Spark, TipRanks' AI Analyst, rates SLQT as Neutral, citing improving fundamentals and a constructive earnings outlook, but is tempered by weak technicals and inconsistent cash flow.

Original reporting
TipRanks · TipRanks Auto-Generated Newsdesk
Published Mar 26, 2026, 1:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 26, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure — source image
Decision brief

The 30-second read

$SLQTNeutralLow
01

Why it matters

The non-compliance could lead to delisting if not remedied within six months, affecting liquidity and investor confidence.

02

Market read

The issue is specific to SLQT’s NYSE listing status but may influence investor sentiment and sector perception.

03

What to watch

Potential for regulatory delays or additional financial challenges that could prolong or worsen the compliance issue.

Timing: short-term (next 1-2 weeks)

Background

SelectQuote has been notified by NYSE about non-compliance due to its share price falling below the listing requirement threshold.

Company-level read

Ticker impact

$SLQTNeutralMedium confidence
Context

Primary focus of the news due to NYSE compliance issue.

Expected impact

Potential short-term decline if delisting concerns intensify; long-term outlook remains uncertain pending compliance and fundamental recovery.

Evidence & confidence

The news indicates a compliance issue with a strategic plan to address it, but no immediate price movement is confirmed. Technical weaknesses and cash flow issues temper optimism.

Market effects

Potential impact on financial services and investment management sectors due to regulatory compliance concerns.

Limited; primarily affects US-listed securities and related market participants.

negligible; specific to US markets and the company's compliance status.

Counterpoint

The company’s efforts to leverage recent financial improvements may successfully restore compliance, leading to a rebound in share price.

Key entities

  • SelectQuote

    A provider of insurance comparison and sales services.

  • NYSE

    New York Stock Exchange, the primary listing venue for SelectQuote.

Related articles

$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges: